Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'

The shots made by U.S. drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatment for HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect against infection.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1YQGMuj
via IFTTT